HomeCAI • NASDAQ
add
Caris Life Sciences Inc
Previous close
$19.22
Day range
$18.49 - $19.26
Year range
$17.15 - $42.50
Market cap
5.24B USD
Avg Volume
2.45M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 292.89M | 125.44% |
Operating expense | 134.37M | 22.83% |
Net income | 81.96M | 321.82% |
Net profit margin | 27.98 | 198.38% |
Earnings per share | 0.28 | — |
EBITDA | 92.70M | 431.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 800.09M | 1,109.50% |
Total assets | 1.13B | 227.48% |
Total liabilities | 548.36M | -11.69% |
Total equity | 577.31M | — |
Shares outstanding | 282.53M | — |
Price to book | 9.42 | — |
Return on assets | 20.95% | — |
Return on capital | 23.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 81.96M | 321.82% |
Cash from operations | 44.78M | 215.05% |
Cash from investing | -5.09M | -122.27% |
Cash from financing | 3.40M | 1,403.98% |
Net change in cash | 43.06M | 205.06% |
Free cash flow | 2.05M | — |
About
Founded
2008
Headquarters
Website
Employees
1,769
